Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06608511
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-19
Brief Title:
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to study blood samples and compare them to other biospecimens and clinical outcomes in participants who have melanoma or non-melanoma skin cancers The main question it aims to answer is
Are blood based signatures able to predict progression-free survival PFS
Participants undergoing regular treatment for their skin cancer will provide blood samples
Are blood based signatures able to predict progression-free survival PFS
Participants undergoing regular treatment for their skin cancer will provide blood samples
Detailed Description:
This observational study is being done to identify possible biomarkers that can be used for prognostic prediction or monitoring considerations in patients with melanoma or non-melanoma skin cancer undergoing treatment Investigators plan to investigate blood factors which include circulating tumor cells CTCs - ie cancer cells that can be detected in the blood and their associated protein and mRNA expression circulating tumor DNA ctDNA - ie pieces of DNA from cancer cells that can be found in the blood and tumor-derived exosomes ie extracellular vesicles generated by cancer cells that carry nucleic acids proteins and metabolites
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None